Details:
Enterin completed the first human clinical trials for ENT-01 which demonstrated that oral administration of its treatment has restored function of the nervous system of the gastrointestinal tract in Parkinson’s patients.
Lead Product(s): ENT-01
Therapeutic Area: Neurology Product Name: ENT-01
Highest Development Status: Phase IIProduct Type: Small molecule
Partner/Sponsor/Collaborator: Enterin
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration March 28, 2022
Details:
Enviero is first-of-its-kind, a green-chemistry progesterone that represents a step change in progesterone API synthesis, is manufactured via a proprietary biocatalytic process based on plant sterols that reduce waste, greenhouse gas emissions and use of hazardous solvents.
Lead Product(s): Progesterone
Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Product Name: Estima
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Effik
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable November 18, 2020